GNA Biosolutions raised €12M in a Series C round in Jul 2019. The company is based in Munich, Germany. Investors in the round: GreyBird Ventures. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
